Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning in Early Prediction of Metabolism of Drugs.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports.

Journal of medical case reports·2021
Same author

Photodynamic therapy and subthreshold micropulse laser treatment - A novel combined approach for the treatment of serous retinal detachment in dome-shaped macula.

Photodiagnosis and photodynamic therapy·2020
Same author

Multimodal Imaging Analysis of Acute Syphilitic Posterior Placoid Chorioretinitis: A Case Report.

Ophthalmic surgery, lasers & imaging retina·2019
Same author

Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.

European journal of ophthalmology·2018
Same author

Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Clinical Spectrum and Multimodal Imaging Characteristics.

Ophthalmology·2017

Related Experiment Video

Updated: Jun 13, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Inflammatory choroidal neovascularization.

Piergiorgi Neri1, Marta Lettieri, Cinzia Fortuna

  • 1The Eye Clinic-Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi-Ancona.

Middle East African Journal of Ophthalmology
|April 21, 2010
PubMed
Summary

Choroidal neovascularization (CNV) from uveitis causes vision loss. Early diagnosis with imaging and treating inflammation, potentially with anti-VEGF agents, is key for managing this severe condition.

Keywords:
Choroidal NeovascularizationChoroiditisImmunosuppressionSteroidsUveitisVascular Endothelial Growth Factor

More Related Videos

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
09:56

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
09:56

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

Area of Science:

  • Ophthalmology
  • Immunology
  • Vascular Biology

Background:

  • Choroidal neovascularization (CNV) is a sight-threatening complication of infectious and noninfectious uveitis.
  • CNV often arises from posterior pole lesions, necessitating accurate diagnostic examinations.

Purpose of the Study:

  • To review diseases associated with CNV secondary to uveitis.
  • To highlight novel treatment modalities and therapeutic strategies for CNV.

Main Methods:

  • Diagnostic imaging techniques including fluorescein angiography (FA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT) are crucial for characterizing CNV.
  • Identifying underlying infectious causes is important for targeted therapy.
  • Management of noninfectious uveitis involves controlling inflammation with systemic corticosteroids and immunosuppressants, even in subclinical cases.

Main Results:

  • Accurate diagnosis of CNV requires thorough examination and advanced imaging.
  • Treatment strategies focus on addressing the underlying cause (infection or inflammation).
  • Intravitreal anti-Vascular Endothelial Growth Factor (VEGF) agents are recommended for refractory cases.

Conclusions:

  • CNV secondary to uveitis results in significant visual impairment.
  • ICGA is essential for assessing choroidal status.
  • Current evidence is limited to case reports and small series, necessitating further clinical trials to establish treatment guidelines.